Clinical Trial Update: DOCICAR: Cardiac Dysfunction in Cirrhosis

View source ↗

Summary

The DOCICAR trial investigating cardiac dysfunction in cirrhosis has completed. It studied cirrhotic cardiomyopathy associated with cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Cirrhotic Cardiomyopathy

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Cirrhosis, Cirrhotic Cardiomyopathy | Status: COMPLETED